T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris.
作者信息
Croitoru David O, Piguet Vincent
机构信息
Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Canada.
Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Canada.
出版信息
J Invest Dermatol. 2023 Aug;143(8):1340-1341. doi: 10.1016/j.jid.2023.02.002. Epub 2023 Mar 21.
Abstract
摘要
相似文献
1
T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris.利妥昔单抗治疗的寻常型天疱疮患者的T细胞记住了新冠病毒。
J Invest Dermatol. 2023 Aug;143(8):1340-1341. doi: 10.1016/j.jid.2023.02.002. Epub 2023 Mar 21.
2
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris.评估使用利妥昔单抗治疗寻常型天疱疮患者对 SARS-CoV-2 感染的易感性。
J Dermatolog Treat. 2022 May;33(3):1606-1607. doi: 10.1080/09546634.2020.1870648. Epub 2021 Jan 12.
3
Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.在 COVID-19 大流行期间用利妥昔单抗治疗寻常型天疱疮：一项叙述性综述。
Dermatol Ther. 2021 Jan;34(1):e14405. doi: 10.1111/dth.14405. Epub 2020 Oct 20.
4
Can rituximab be used in the treatment of pemphigus vulgaris during the COVID-19 pandemic?在 COVID-19 大流行期间，可以用利妥昔单抗治疗寻常型天疱疮吗？
Dermatol Ther. 2021 Jan;34(1):e14647. doi: 10.1111/dth.14647. Epub 2020 Dec 15.
5
SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris.利妥昔单抗治疗的寻常型天疱疮患者中SARS-CoV-2疫苗的有效性
J Invest Dermatol. 2023 Aug;143(8):1601-1604. doi: 10.1016/j.jid.2022.12.023. Epub 2023 Jan 28.
6
Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab.针对接受利妥昔单抗治疗的天疱疮患者的新冠疫苗接种策略
J Am Acad Dermatol. 2021 Apr;84(4):e197-e198. doi: 10.1016/j.jaad.2020.10.075. Epub 2020 Oct 29.
7
COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: a tele-medicine experience.接受过利妥昔单抗治疗的寻常型天疱疮患者中的新型冠状病毒肺炎：远程医疗经验
J Dermatolog Treat. 2022 Mar;33(2):1181-1182. doi: 10.1080/09546634.2020.1789041. Epub 2020 Jul 9.
8
Clinical resolution of pemphigus vulgaris on rituximab.寻常型天疱疮经利妥昔单抗治疗后的临床缓解
Dermatol Online J. 2017 Sep 15;23(9):13030/qt3bc1z047.
9
Treatment of pemphigus patients in the COVID-19 era: A specific focus on rituximab.新冠疫情时代天疱疮患者的治疗：特别关注利妥昔单抗。
Dermatol Ther. 2020 Nov;33(6):e14188. doi: 10.1111/dth.14188. Epub 2020 Sep 3.
10
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns.一项关于低剂量利妥昔单抗治疗天疱疮的疗效、安全性和治疗持久性的系统评价：特别关注 COVID-19 大流行相关问题。
Immunopharmacol Immunotoxicol. 2021 Oct;43(5):507-518. doi: 10.1080/08923973.2021.1953063. Epub 2021 Jul 21.
Zotero 插件